FDA Inspection
McGuff Pharmaceuticals, Inc.McGuff Pharmaceuticals, Inc. – FDA Inspection, Dec 31, 2014
Record Details
This FDA Inspection record concerns McGuff Pharmaceuticals, Inc., with an inspection on December 31, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- McGuff Pharmaceuticals, Inc.
- Inspection Date
- December 31, 2014
- Product Type
- Drugs
View Company Profile
ID · 70c27e45-066c-445c-8719-327529991c4d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 908368
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.167(a)Sterility/pyrogen-free testing
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of McGuff Pharmaceuticals, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| August 20, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2024 | VAI | Los Angeles District Office | New Drug Evaluation |
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for McGuff Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.